Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
3.770
-0.020 (-0.53%)
Feb 21, 2025, 4:00 PM EST - Market closed
Artiva Biotherapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Artiva Biotherapeutics stock have an average target of 21, with a low estimate of 18 and a high estimate of 23. The average target predicts an increase of 457.03% from the current stock price of 3.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 30, 2024.
Analyst Ratings
The average analyst rating for Artiva Biotherapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +430.50% | Dec 30, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +510.08% | Nov 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +510.08% | Aug 30, 2024 |
| Needham | Needham | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +510.08% | Aug 13, 2024 |
| Wedbush | Wedbush | Buy Initiates $18 | Buy | Initiates | $18 | +377.45% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
272.51K
from 33.49M
Decreased by -99.19%
Revenue Next Year
n/a
from 272.51K
EPS This Year
-5.42
from -35.78
EPS Next Year
-3.08
from -5.42
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 577,500 | n/a | n/a |
| Avg | 272,513 | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -98.3% | - | - |
| Avg | -99.2% | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.81 | -2.54 | -0.82 |
| Avg | -5.42 | -3.08 | -2.44 |
| Low | -6.22 | -3.49 | -3.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.